Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.
- DOI
- 10.1016/j.jtocrr.2026.101048
- Published
- 2026 Sep
- Container
- JTO clinical and research reports
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtocrr.2026.101048,
title = {Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.},
author = {Komuta K and Matsumoto K and Tamiya M and Shiroyama T and Kinehara Y and Tamiya A and Kuge T and Uchida J and Suzuki H and Yamamoto S and Tobita S and Niki T and Tetsumoto S and Morimura O and Osa A and Minami T and Nishino K and Takeda Y and Kumanogoh A},
year = {2026},
journal = {JTO clinical and research reports},
doi = {10.1016/j.jtocrr.2026.101048},
url = {https://doi.org/10.1016/j.jtocrr.2026.101048}
}RIS
TY - JOUR TI - Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study. AU - Komuta K AU - Matsumoto K AU - Tamiya M AU - Shiroyama T AU - Kinehara Y AU - Tamiya A AU - Kuge T AU - Uchida J AU - Suzuki H AU - Yamamoto S AU - Tobita S AU - Niki T AU - Tetsumoto S AU - Morimura O AU - Osa A AU - Minami T AU - Nishino K AU - Takeda Y AU - Kumanogoh A PY - 2026 JO - JTO clinical and research reports DO - 10.1016/j.jtocrr.2026.101048 UR - https://doi.org/10.1016/j.jtocrr.2026.101048 ER -
APA
K, K., K, M., M, T., T, S., Y, K., A, T., T, K., J, U., H, S., S, Y., S, T., T, N., S, T., O, M., A, O., T, M., K, N., Y, T., & A, K. (2026). Comparison of Long-Term Survival Between Nivolumab Plus Ipilimumab and Nivolumab Plus Ipilimumab With Chemotherapy in Advanced NSCLC: A Multicenter Retrospective Cohort Study.. JTO clinical and research reports. https://doi.org/10.1016/j.jtocrr.2026.101048
Source records
- pubmed · retrieved 2026-09-26T02:39:06.697Z